Drug retailers, makers face mounting litigation over decongestant products (CVS)


FDA Advisory Panel Finds Common Decongestant Ineffective

Joe Raedle/Getty Images News

CVS’s decision to pull oral medications that contain the controversial decongestant phenylephrine comes as it and several other leading OTC drugmakers and retailers face a growing number of lawsuits related to the drug’s effectiveness.

Earlier Thursday, The Wall Street Journal reported

Source link

Leave A Reply

Your email address will not be published.